Open-Label, Extension Study to 810P202

Clinical trial NCT01416064 · COMPLETED

Trial details

NCT number

NCT01416064

Sponsor

Supernus Pharmaceuticals, Inc.

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2011-09-01

Primary completion

2013-01-01

Enrollment

78

View on ClinicalTrials.gov